Yissum - Research Development Company of the Hebrew University

High-Throughput Sequencing Methods to Test Samples

Posted by Yissum - Research Development Company of the Hebrew UniversityResponsive · Innovative Products and Technologies · Israel

Summary of the technology

Highly parallel test for the presence of SARS-CoV-2
Project ID : 47-2020-10893

Yissum - Research Development Company of the Hebrew University

Description of the technology

The currently used test for SARS-CoV2 virus uses molecular methods for detecting the presence of viral RNA sequences in subject samples. This is the approved gold standard in the field. The current application of this test requires several cumbersome steps that are labor intensive and require non-trivial reagents (which are becoming a global bottleneck). It is clear that during the next stage of managing the COVID19 pandemic, large scale testing will be needed.

We are developing an approach that harness high-throughput sequencing methods to test samples. The working guidelines are to adhere to current collection protocols and clinical test definitions and standards. We replace labor intensive molecular steps with alternative ones that are based on our expertise in high-throughput genomics.

Briefly, the approach will allow one technician to process thousands samples per day using a simple protocol. Thousands of samples (10,000 or more)will be read by a single sequencing run, with straightforward calling of results using simple bioinformatic tools.

Benefits:

  • Use the same set of probes as current gold standard tests
  • Readout directly comparable to current tests and can adhere to the same standards
  • High-throughput (thousands of samples)
  • Automation friendly (can be readily automated)

Low cost in terms of reagents and readout

Project manager

Keren-Or Amar
VP, Business Development, Healthcare

Project researchers

Nir Friedman
HUJI, Faculty of Science
The Alexander Silberman Institute for Life Sciences

Naomi Habib
HUJI, Faculty of Science
The Edmond and Lily Safra Center for Brain Sciences

Related keywords

  • In vitro Testing, Trials Technology
  • Infectious Diseases
  • Genetic Engineering / Molecular Biology
  • Micro- and Nanotechnology related to Biological sciences
  • Covid-19
  • covid-19
  • high-throughtput

About Yissum - Research Development Company of the Hebrew University

Technology Transfer Office from Israel

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Founded in 1964 to protect and commercialize the Hebrew University’s intellectual property. Ranked among the top technology transfer companies, Yissum has registered over 8,900 patents covering 2,500 inventions; has licensed out 800 technologies and has spun-off 90 companies. Products that are based on Hebrew University technologies and were commercialized by Yissum generate today over $2 Billion in annual sales.

Send your request

By clicking "Send your request" you are signing up and accepting our Terms of Service and Privacy policy

Technology Offers on Innoget are directly posted and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.